4//SEC Filing
GORDON CARL L 4
Accession 0000947871-23-000336
CIK 0001739174other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:29 PM ET
Size
14.2 KB
Accession
0000947871-23-000336
Insider Transaction Report
Form 4
BiomX Inc.PHGE
Transactions
- Purchase
Common Stock
2023-02-27$0.24/sh+348,000$85,260→ 3,161,489 total(indirect: See Footnotes) - Purchase
Warrants (Right to Buy)
2023-02-27+1,789,959→ 1,789,959 total(indirect: See Footnotes)Exercise: $0.24From: 2023-02-27Exp: 2033-02-27→ Common Stock (1,789,959 underlying)
OrbiMed Israel GP Ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-02-27$0.24/sh+348,000$85,260→ 3,161,489 total(indirect: See Footnotes) - Purchase
Warrants (Right to Buy)
2023-02-27+1,789,959→ 1,789,959 total(indirect: See Footnotes)Exercise: $0.24From: 2023-02-27Exp: 2033-02-27→ Common Stock (1,789,959 underlying)
GORDON CARL L
10% Owner
Transactions
- Purchase
Common Stock
2023-02-27$0.24/sh+348,000$85,260→ 3,161,489 total(indirect: See Footnotes) - Purchase
Warrants (Right to Buy)
2023-02-27+1,789,959→ 1,789,959 total(indirect: See Footnotes)Exercise: $0.24From: 2023-02-27Exp: 2033-02-27→ Common Stock (1,789,959 underlying)
Chimovits Erez
Director
Transactions
- Purchase
Common Stock
2023-02-27$0.24/sh+348,000$85,260→ 3,161,489 total(indirect: See Footnotes) - Purchase
Warrants (Right to Buy)
2023-02-27+1,789,959→ 1,789,959 total(indirect: See Footnotes)Exercise: $0.24From: 2023-02-27Exp: 2033-02-27→ Common Stock (1,789,959 underlying)
Footnotes (3)
- [F1]These shares of the Issuer's common stock and warrants to purchase shares of the Issuer's common stock were purchased from the Issuer in a private placement. The warrants are exercisable for one share of the Issuer's common stock per warrant, subject to an issuance limitation that prohibits the holder from exercising the warrants to the extent that after giving effect to such issuance after exercise, the holder (together with the holder's affiliates and any other persons acting as a group together with the holder or any of the holder's affiliates, including the Reporting Persons) would beneficially own in excess of 9.99% of the shares of common stock outstanding immediately after giving effect to the issuance of the shares of common stock issuance upon exercise of the warrants.
- [F2]These securities are held of record by OrbiMed Israel Partners Limited Partnership ("OIP"). OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP and OrbiMed Israel GP Ltd. ("OrbiMed Israel") is the general partner of OrbiMed BioFund. By virtue of such relationships, OrbiMed Israel and OrbiMed BioFund may be deemed to have voting and investment power over the securities held by OIP and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Israel exercises investment and voting power through an investment committee comprised of Carl L. Gordon and Erez Chimovits.
- [F3]Each of OrbiMed Israel, OrbiMed BioFund, Carl Gordon, and Erez Chimovits disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
BiomX Inc.
CIK 0001739174
Entity typeother
Related Parties
1- filerCIK 0001282930
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:29 PM ET
- Size
- 14.2 KB